Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

PubWeight™: 9.07‹?› | Rank: Top 0.1%

🔗 View Article (PMID 10644669)

Published in J Biol Chem on January 28, 2000

Authors

S L Friedman1

Author Affiliations

1: Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029, USA. frieds02@doc.mssm.edu

Associated clinical trials:

Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium | NCT01783314

Articles citing this

(truncated to the top 100)

Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28

Liver cirrhosis. Lancet (2008) 6.11

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut (2005) 5.39

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest (2007) 4.41

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med (2006) 3.84

CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest (2009) 3.62

Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A (2006) 2.75

CCR2 promotes hepatic fibrosis in mice. Hepatology (2009) 2.35

Apoptosis: a mechanism of acute and chronic liver injury. Gut (2005) 2.33

Retinoid absorption and storage is impaired in mice lacking lecithin:retinol acyltransferase (LRAT). J Biol Chem (2005) 2.28

TGF-β in progression of liver disease. Cell Tissue Res (2011) 2.22

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology (2002) 2.10

A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury. J Hepatol (2013) 2.08

StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut (2011) 2.07

Vitamin A metabolism: an update. Nutrients (2011) 1.99

LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res (2013) 1.91

DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89

Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut (2002) 1.82

Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol (2006) 1.79

The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep (2001) 1.76

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest (2003) 1.73

Redox control of the cell cycle in health and disease. Antioxid Redox Signal (2009) 1.72

Transcriptional regulation of hepatic stellate cell activation. Gut (2002) 1.66

Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Biol Cell (2005) 1.65

Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut (2010) 1.63

Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. Radiology (2012) 1.62

Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J (2004) 1.61

Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem (2010) 1.58

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol (2005) 1.53

Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun (2007) 1.52

Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol (2003) 1.50

Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol (2010) 1.49

Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47

Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut (2003) 1.47

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact (2011) 1.44

Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42

Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep (2010) 1.37

Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ (2003) 1.37

Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology (2001) 1.36

Hepatitis C virus infection and apoptosis. World J Gastroenterol (2007) 1.36

Role of free radicals in liver diseases. Hepatol Int (2009) 1.36

Lymphocyte-hepatic stellate cell proximity suggests a direct interaction. Clin Exp Immunol (2007) 1.35

Lhx2-/- mice develop liver fibrosis. Proc Natl Acad Sci U S A (2004) 1.33

Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut (2006) 1.31

Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair (2008) 1.30

Advances in gene therapy of liver cirrhosis: a review. World J Gastroenterol (2001) 1.30

NOX in liver fibrosis. Arch Biochem Biophys (2007) 1.29

Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J (2004) 1.27

Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol (2009) 1.27

Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol (2005) 1.27

A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol (2006) 1.24

Immune interactions in hepatic fibrosis. Clin Liver Dis (2008) 1.23

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol (2008) 1.23

Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. J Thromb Haemost (2006) 1.22

Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol (2005) 1.22

Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver. Am J Pathol (2002) 1.22

Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health (2010) 1.22

Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J Hepatol (2005) 1.21

Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut (2005) 1.20

Molecular serum markers of liver fibrosis. Biomark Insights (2012) 1.20

Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem (2003) 1.19

Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis. J Clin Invest (2005) 1.19

Inflammatory pseudo-tumor of the liver: a rare pathological entity. World J Surg Oncol (2011) 1.19

Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. J Lipid Res (2008) 1.18

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology (2011) 1.17

Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol (2002) 1.17

Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology (2009) 1.17

Distinct populations of hepatic stellate cells in the mouse liver have different capacities for retinoid and lipid storage. PLoS One (2011) 1.15

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation. Cell Biosci (2012) 1.15

Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol (2006) 1.14

Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring. Wound Repair Regen (2007) 1.14

Hepatic metabolism of retinoids and disease associations. Biochim Biophys Acta (2011) 1.13

Characterization of the interaction between alphaCP(2) and the 3'-untranslated region of collagen alpha1(I) mRNA. Nucleic Acids Res (2000) 1.13

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis. Korean J Hepatol (2011) 1.13

microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget (2015) 1.12

Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J (2005) 1.11

TNFalpha is required for cholestasis-induced liver fibrosis in the mouse. Biochem Biophys Res Commun (2008) 1.11

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol (2002) 1.11

Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion. PLoS One (2013) 1.10

Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut (2001) 1.10

Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal (2014) 1.10

Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. Hepatology (2008) 1.10

Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells. Biol Reprod (2009) 1.09

Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer (2010) 1.09

Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med (2009) 1.09

A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling. Gastroenterology (2011) 1.09

Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis (2009) 1.08

Cell migration: a novel aspect of pancreatic stellate cell biology. Gut (2003) 1.08

Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol (2003) 1.08

Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol (2003) 1.08

Diurnal regulation of the early growth response 1 (Egr-1) protein expression by hepatocyte nuclear factor 4alpha (HNF4alpha) and small heterodimer partner (SHP) cross-talk in liver fibrosis. J Biol Chem (2011) 1.07

Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol (2005) 1.07

Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem (2012) 1.07

Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol (2011) 1.06

Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J Gastroenterol (2002) 1.06

Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol (2014) 1.06

Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med (2007) 1.06

Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism. Hepatology (2008) 1.05

Succinate is a paracrine signal for liver damage. J Hepatol (2007) 1.04